Skip to content

A study to assess the effect of high sodium dialysate in critically ill patients undergoing slow low efficiency dialysis on serum sodium

Evaluation of high sodium dialysate prescription on the trajectory of serum sodium in critically ill patients with acute kidney injury undergoing sustained low efficiency dialysis (SLED): A prospective observational study - ISAKI trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110604
Enrollment
90
Registered
2026-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N171- Acute kidney failure with acute cortical necrosis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: No intervention: No intervention

Sponsors

PV Sai Saran
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Critically ill adults aged 18 years and above 2.Non renal SOFA score more than 6 3.Acute Kidney Injury stage 2 or higher based on KDIGO criteria 4. Patients initiated on renal replacement therapy

Exclusion criteria

Exclusion criteria: 1.End stage renal disease on maintenance hemodialysis 2.Patients with pre-existing dysnatremia defined as Pre SLED serum Na less than 125 or more than 147mEq per L which are not compatible with the dialysate sodium protocol of study OR couldnt fit into existing dialysis machine 128 to 155 mEq per L 3. Ongoing therapies that substantially alter sodium balance such as hypertonic saline infusion 4. Pregnant patients 5. Chronic liver disease 6. Variations in SLED prescription such as Na and UF profiling other than constant pattern

Design outcomes

Primary

MeasureTime frame
rate and magnitude of serum sodium change in mEq per L per session in critically ill patients undergoing sustained low efficiency dialysis SLEDTimepoint: 15 minutes before SLED and 15 minutes after SLED

Secondary

MeasureTime frame
Incidence of hemodynamic instability related to renal replacement therapy HIRRT Dialysis adequacy measured by Kt V & urea reduction ratioTimepoint: Baseline, 15 minutes after initiation, 30 minutes, 1 hour after initiation,2 hours after initiation, 4hours after initiation Kt V & urea reduction ratio will be assesed before & after SLED.

Countries

India

Contacts

Public ContactSai Saran

Sanjay gandhi postgraduate institute of medical sciences

saisaranpv@gmail.com8004505719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026